![Foto de MARÍA](/img/nophoto.png)
MARÍA
DE LAGARDE SEBASTIÁN
Profesora asociada de Ciencias de la Salud
Publicacións (41) Publicacións de MARÍA DE LAGARDE SEBASTIÁN
2024
-
Fibrocavitary disease caused by Mycobacterium chimaera in a patient with HIV
AIDS
-
Life expectancy of people with HIV on antiretroviral therapy in Spain
AIDS, Vol. 38, Núm. 3, pp. 387-395
-
Transition times across the HIV care continuum in Spain from 2005 to 2022: a longitudinal cohort study
The Lancet HIV, Vol. 11, Núm. 7, pp. e470-e478
2023
-
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 11, pp. 2696-2701
2022
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
HIV Medicine, Vol. 23, Núm. 7, pp. 705-716
-
Incidence and Severity of SARS-CoV-2 Infection in HIV-Infected Individuals during the First Year of the Pandemic
Journal of Acquired Immune Deficiency Syndromes, Vol. 89, Núm. 5, pp. 511-518
-
Infecciones por el virus de la inmunodeficiencia humana
Manual de diagnóstico y terapéutica médica (Hospital Universitario 12 de Octubre), pp. 1139-1161
-
Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance
Open Forum Infectious Diseases, Vol. 9, Núm. 11
2021
-
Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery
The Journal of infectious diseases, Vol. 223, Núm. 3, pp. 471-481
-
Different HCV exposure drives specific miRNA profile in PBMCS of HIV patients
Biomedicines, Vol. 9, Núm. 11
2020
-
How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain
HIV Medicine, Vol. 21, Núm. 2, pp. 128-134
-
Sustained virological response at week 12 after interferon-free therapy as criterion for HCV cure definition: Validation in a real-life cohort of HIV-coinfected patients
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 6, pp. 275-278
2019
-
Effects of immunonutrition in advanced human immunodeficiency virus disease: A randomized placebo-controlled clinical trial (Promaltia study)
Clinical Infectious Diseases, Vol. 68, Núm. 1, pp. 120-130
-
HCV eradication with all-oral therapy in cirrhotic HIV-coinfected patients: an observational study of early changes in liver function and fibrosis tests
Revista Española de Enfermedades Digestivas, Vol. 111, Núm. 8, pp. 626-632
-
HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study
Scientific Reports, Vol. 9, Núm. 1
-
Predictive factors of hepatitis C virus eradication after interferon-free therapy in HIV coinfection
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 4, pp. 725-734
-
Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles
Microbial Pathogenesis, Vol. 128, pp. 112-118
2018
-
Erratum: Effects of immunonutrition in advanced human immunodeficiency virus disease: A randomized placebo-controlled clinical trial (Promaltia study) (Clinical Infectious Diseases DOI: 10.1093/cid/ciy414)
Clinical Infectious Diseases
-
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Medicine (United States), Vol. 97, Núm. 38